90 results
8-K
EX-10.3
PMCB
PharmaCyte Biotech Inc
15 Nov 23
New investment marks expansion of corporate strategy to utilize significant cash position to create additional shareholder value
8:45pm
8-K
EX-10.4
PMCB
PharmaCyte Biotech Inc
15 Nov 23
New investment marks expansion of corporate strategy to utilize significant cash position to create additional shareholder value
8:45pm
8-K
EX-10.1
PMCB
PharmaCyte Biotech Inc
15 Nov 23
New investment marks expansion of corporate strategy to utilize significant cash position to create additional shareholder value
8:45pm
8-K
EX-10.2
PMCB
PharmaCyte Biotech Inc
15 Nov 23
New investment marks expansion of corporate strategy to utilize significant cash position to create additional shareholder value
8:45pm
8-K
EX-10.3
PMCB
PharmaCyte Biotech Inc
11 May 23
PharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000
8:30am
8-K
EX-10.2
qhbhgli
11 May 23
PharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000
8:30am
8-K
EX-10.1
5ysgv25586sttzeh
11 May 23
PharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000
8:30am
8-K
EX-10.1
4bpucmy
14 Oct 22
Departure of Directors or Certain Officers
4:12pm
8-K
EX-10.1
d1bo1ag e31ik
7 Oct 22
PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value
4:53pm
8-K
EX-10.2
3yam3gyf4jm
15 Aug 22
Company Appoints Five New Independent Directors to Reconstituted Board
6:55pm
8-K
EX-10.1
fnj5n4
15 Aug 22
Company Appoints Five New Independent Directors to Reconstituted Board
6:55pm
DEFA14A
EX-10.1
yp33ywre
15 Aug 22
Additional proxy soliciting materials
6:53pm
DEFA14A
EX-10.2
1a20mewg 7ms6
15 Aug 22
Additional proxy soliciting materials
6:53pm
8-K
EX-10.1
hl9 ezldtu
23 Aug 21
PharmaCyte Biotech Announces $70 Million Registered Direct Offering
6:01am
8-K
EX-10.1
at8g7h tl
16 Oct 20
Departure of Directors or Certain Officers
4:57pm